DcR3 suppresses the NF-κB pathway and the NLRP3 inflammasome activation in gouty inflammation

Yi Jiang; Xin Tu; Jianwei Guo; Jianxiong Zheng; Xia Liao; Yixi He; Yan Xie; Quanbo Zhang; Yufeng Qing

doi:10.1097/CM9.0000000000003274

DcR3 suppresses the NF-κB pathway and the NLRP3 inflammasome activation in gouty inflammation

Chin Med J (Engl). 2024 Nov 5;137(21):2644-2646. doi: 10.1097/CM9.0000000000003274. Epub 2024 Sep 19.

Authors

Yi Jiang^{1

2}, Xin Tu^{1

3}, Jianwei Guo^{1

3}, Jianxiong Zheng^{1

2}, Xia Liao^{1

2}, Yixi He^{1

2}, Yan Xie^{1

2}, Quanbo Zhang^{1

3}, Yufeng Qing^{1

2}

Affiliations

¹ Research Center of Hyperuricemia and Gout, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan 637000, China.
² Department of Rheumatology and Immunology, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan 637000, China.
³ Department of Geriatrics, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan 637000, China.

No abstract available